Table of Contents
2019-2024 Global Gabapentin Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gabapentin Consumption 2014-2024
2.1.2 Gabapentin Consumption CAGR by Region
2.2 Gabapentin Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Consumption by Type
2.3.1 Global Gabapentin Consumption Market Share by Type (2014-2019)
2.3.2 Global Gabapentin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Gabapentin Sale Price by Type (2014-2019)
2.4 Gabapentin Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin Consumption by Application
2.5.1 Global Gabapentin Consumption Market Share by Application (2014-2019)
2.5.2 Global Gabapentin Value and Market Share by Application (2014-2019)
2.5.3 Global Gabapentin Sale Price by Application (2014-2019)
3 Global Gabapentin by Players
3.1 Global Gabapentin Sales Market Share by Players
3.1.1 Global Gabapentin Sales by Players (2017-2019)
3.1.2 Global Gabapentin Sales Market Share by Players (2017-2019)
3.2 Global Gabapentin Revenue Market Share by Players
3.2.1 Global Gabapentin Revenue by Players (2017-2019)
3.2.2 Global Gabapentin Revenue Market Share by Players (2017-2019)
3.3 Global Gabapentin Sale Price by Players
3.4 Global Gabapentin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Gabapentin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Gabapentin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Gabapentin by Regions
4.1 Gabapentin by Regions
4.1.1 Global Gabapentin Consumption by Regions
4.1.2 Global Gabapentin Value by Regions
4.2 Americas Gabapentin Consumption Growth
4.3 APAC Gabapentin Consumption Growth
4.4 Europe Gabapentin Consumption Growth
4.5 Middle East & Africa Gabapentin Consumption Growth
5 Americas
5.1 Americas Gabapentin Consumption by Countries
5.1.1 Americas Gabapentin Consumption by Countries (2014-2019)
5.1.2 Americas Gabapentin Value by Countries (2014-2019)
5.2 Americas Gabapentin Consumption by Type
5.3 Americas Gabapentin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Gabapentin Consumption by Countries
6.1.1 APAC Gabapentin Consumption by Countries (2014-2019)
6.1.2 APAC Gabapentin Value by Countries (2014-2019)
6.2 APAC Gabapentin Consumption by Type
6.3 APAC Gabapentin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Gabapentin by Countries
7.1.1 Europe Gabapentin Consumption by Countries (2014-2019)
7.1.2 Europe Gabapentin Value by Countries (2014-2019)
7.2 Europe Gabapentin Consumption by Type
7.3 Europe Gabapentin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Gabapentin by Countries
8.1.1 Middle East & Africa Gabapentin Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Gabapentin Value by Countries (2014-2019)
8.2 Middle East & Africa Gabapentin Consumption by Type
8.3 Middle East & Africa Gabapentin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gabapentin Distributors
10.3 Gabapentin Customer
11 Global Gabapentin Market Forecast
11.1 Global Gabapentin Consumption Forecast (2019-2024)
11.2 Global Gabapentin Forecast by Regions
11.2.1 Global Gabapentin Forecast by Regions (2019-2024)
11.2.2 Global Gabapentin Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gabapentin Forecast by Type
11.8 Global Gabapentin Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Gabapentin Product Offered
12.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 Depomed
12.2.1 Company Details
12.2.2 Gabapentin Product Offered
12.2.3 Depomed Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Depomed News
12.3 TEVA
12.3.1 Company Details
12.3.2 Gabapentin Product Offered
12.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 TEVA News
12.4 Mylan
12.4.1 Company Details
12.4.2 Gabapentin Product Offered
12.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Arbor Pharma
12.5.1 Company Details
12.5.2 Gabapentin Product Offered
12.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Arbor Pharma News
12.6 Novartis
12.6.1 Company Details
12.6.2 Gabapentin Product Offered
12.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Novartis News
12.7 Apotex
12.7.1 Company Details
12.7.2 Gabapentin Product Offered
12.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Apotex News
12.8 Sun Pharmaceutical
12.8.1 Company Details
12.8.2 Gabapentin Product Offered
12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Sun Pharmaceutical News
12.9 Aurobindo Pharma
12.9.1 Company Details
12.9.2 Gabapentin Product Offered
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Aurobindo Pharma News
12.10 Intas
12.10.1 Company Details
12.10.2 Gabapentin Product Offered
12.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Intas News
12.11 Amneal
12.12 Marksans Pharma
12.13 Glenmark
12.14 Alkem
12.15 Jiangsu Enhua
12.16 Jiangsu Hengrui
12.17 Sailike
13 Research Findings and Conclusion
【免責事項】
https://www.globalresearch.jp/disclaimer